R. Michael Baldwin
- Oncology top 10%
- Pharmacology top 1%
- Molecular Biology
- Cancer Research
- Hematology top 10%
- Co-authors
- Alan R. BuckpittMagnus Ingelman‐SundbergJessica MwinyiRasmus S. PedersenLeif BertilssonErik EliassonMichael A. ShultzCharles G. Plopper
- Topics
- Pharmacogenetics and Drug Metabolism (9 papers)Chemical Reactions and Isotopes (4 papers)Drug Transport and Resistance Mechanisms (3 papers)
- Cited by
- PharmacologyOncologyCancer Research
- Journals
- Clinical Cancer ResearchJournal of Pharmacology and Experimental TherapeuticsInternational Journal of Obesity
- Partner nations
- United StatesSwedenJapan
In The Last Decade
R. Michael Baldwin
18 papers receiving 830 citations
Peers
Comparison fields: 5 of 96
- Oncology 323
- Pharmacology 294
- Molecular Biology 213
- Cancer Research 126
- Hematology 80
Countries citing papers authored by R. Michael Baldwin
This map shows the geographic impact of R. Michael Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Michael Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Michael Baldwin more than expected).
Fields of papers citing papers by R. Michael Baldwin
This network shows the impact of papers produced by R. Michael Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Michael Baldwin. The network helps show where R. Michael Baldwin may publish in the future.
Co-authorship network of co-authors of R. Michael Baldwin
This figure shows the co-authorship network connecting the top 25 collaborators of R. Michael Baldwin. A scholar is included among the top collaborators of R. Michael Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Michael Baldwin. R. Michael Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 41 | |
| 4 | 26 | |
| 5 | 49 | |
| 6 | 160 | |
| 7 | 31 | |
| 8 | 4 | |
| 9 | 38 | |
| 10 | 20 | |
| 11 | 119 | |
| 12 | 39 | |
| 13 | 53 | |
| 14 | 34 | |
| 15 | 19 | |
| 16 | 42 | |
| 17 | 27 | |
| 18 | 108 | |
| 19 | 35 |
About R. Michael Baldwin
R. Michael Baldwin is a scholar working on Pharmacology, Pharmaceutical Science and Biochemistry, having authored 19 papers that have together received 849 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Chemical Reactions and Isotopes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (294 citations), Oncology (323 citations) and Cancer Research (126 citations). R. Michael Baldwin has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Alan R. Buckpitt, Magnus Ingelman‐Sundberg, Jessica Mwinyi, Rasmus S. Pedersen, Leif Bertilsson, Erik Eliasson, Michael A. Shultz, Charles G. Plopper, Deanna L. Kroetz and Mark J. Ratain. Their work appears in journals such as Clinical Cancer Research, Journal of Pharmacology and Experimental Therapeutics and International Journal of Obesity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.